We are glad to announce that PHIL Inter Pharma has been accredited with

EU-GMP(Good Manufacturing Practice)!

In October 2016, Its softgel manufacturing lines were inspected by MHRA(Medicines and Healthcare products

Regulatory Agency), UK drug authority in accordance with EU-GMP

guidelines and EU-GMP certification was finally approved in December 2016.

We are supposed to receive the MA(Marketing Authorization) for Ibuprofen 200 mg in UK, Germany and

Ireland within the end of 2017, which is our 1st product in EU. From 2018, we will also proceed with MAs for

Dutasteride 0.5 mg, Alfacalcidol 0.25, 0.5 and 0.1 mcg, Omega-3-acid ethyl esters 90 1,000mg,

Choline alfoscerate 400 mg, etc.

The certification backs up our commitment to maintain high level of manufacturing standards and stringent

quality management system to attain customer satisfaction.

We are proud and glad to share this achievement with our partners.